1. Home
  2. AVTX vs TMQ Comparison

AVTX vs TMQ Comparison

Compare AVTX & TMQ Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • AVTX
  • TMQ
  • Stock Information
  • Founded
  • AVTX 2011
  • TMQ 2004
  • Country
  • AVTX United States
  • TMQ Canada
  • Employees
  • AVTX N/A
  • TMQ N/A
  • Industry
  • AVTX Biotechnology: Pharmaceutical Preparations
  • TMQ Precious Metals
  • Sector
  • AVTX Health Care
  • TMQ Basic Materials
  • Exchange
  • AVTX Nasdaq
  • TMQ Nasdaq
  • Market Cap
  • AVTX 88.4M
  • TMQ 83.6M
  • IPO Year
  • AVTX 2015
  • TMQ N/A
  • Fundamental
  • Price
  • AVTX $7.12
  • TMQ $1.32
  • Analyst Decision
  • AVTX Strong Buy
  • TMQ
  • Analyst Count
  • AVTX 4
  • TMQ 0
  • Target Price
  • AVTX $33.00
  • TMQ N/A
  • AVG Volume (30 Days)
  • AVTX 43.8K
  • TMQ 365.0K
  • Earning Date
  • AVTX 03-28-2025
  • TMQ 02-14-2025
  • Dividend Yield
  • AVTX N/A
  • TMQ N/A
  • EPS Growth
  • AVTX N/A
  • TMQ N/A
  • EPS
  • AVTX N/A
  • TMQ N/A
  • Revenue
  • AVTX $820,000.00
  • TMQ N/A
  • Revenue This Year
  • AVTX N/A
  • TMQ N/A
  • Revenue Next Year
  • AVTX N/A
  • TMQ N/A
  • P/E Ratio
  • AVTX N/A
  • TMQ N/A
  • Revenue Growth
  • AVTX N/A
  • TMQ N/A
  • 52 Week Low
  • AVTX $4.18
  • TMQ $0.25
  • 52 Week High
  • AVTX $34.46
  • TMQ $1.48
  • Technical
  • Relative Strength Index (RSI)
  • AVTX 39.94
  • TMQ 56.25
  • Support Level
  • AVTX $7.42
  • TMQ $1.26
  • Resistance Level
  • AVTX $8.00
  • TMQ $1.38
  • Average True Range (ATR)
  • AVTX 0.60
  • TMQ 0.07
  • MACD
  • AVTX -0.02
  • TMQ -0.00
  • Stochastic Oscillator
  • AVTX 3.90
  • TMQ 41.84

About AVTX Avalo Therapeutics Inc.

Avalo Therapeutics Inc is a clinical stage biotechnology company focused on the treatment of immune dysregulation. The company's lead asset is AVTX-009, an anti-IL-1B monoclonal antibody ("mAb"), targeting inflammatory diseases. Avalo's pipeline also includes quisovalimab (anti-LIGHT mAb) and AVTX-008 (BTLA agonist fusion protein).

About TMQ Trilogy Metals Inc.

Trilogy Metals Inc is an exploration stage company engaged in mineral exploration. The company focuses on exploring and developing its mineral resource properties, which include the Upper Kobuk Mineral Projects (UKMP or UKMP Projects), in the Ambler mining district located in Alaska, the United States. Its properties include the Arctic copper-zinc-lead-gold-silver project and other mineralized targets within a volcanogenic massive sulfide belt, and it also has a bornite carbonate-hosted copper project.

Share on Social Networks: